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Summary
Hypertrophic obstructive cardiomyopathy (HOCM) is a rare genetic disorder characterized 
by left ventricular outflow tract (LVOT) obstruction. Clinical presentation ranges from absence of 
symptoms to sudden death. Our 60 year old patient scheduled for left modified radical mastectomy 
had HOCM since seventeen years with severe LVOT obstruction and mitral regurgitation. An 
implantable cardioverter defibrillator (ICD) and permanent pacemaker (PPM) was inserted 15 
months earlier for ventricular tachycardia. Anesthetic management of these patients presents 
considerable challenges and requires maintenance of desired hemodynamic parameters and 
management of specific complications. Factors like tachycardia, hypovolemia, vasodilation and 
increased cardiac contractility leads to exacerbation of the obstruction. In our patient there was the 
additional consideration of the ICD which required to be turned off during surgery with full provision 
for external defibrillation. We managed to successfully maintain the desired hemodynamics 
throughout the surgery and the patient was discharged home on the seventh postoperative day.
Introduction 
Hypertrophic obstructive cardiomyopathy (HOCM) is a rare disorder characterized by 
massive asymmetric hypertrophy of the myocardium resulting in left ventricular outflow tract 
(LVOT) obstruction1. Clinical presentation ranges from absence of symptoms to sudden unexpected 
death2. Decrease in venous return and systemic vascular resistance or increase in myocardial 
contractility worsens the LVOT obstruction3. These patients are highly prone to arrhythmias like 
atrial fibrillation and ventricular tachycardia (VT)2. Management of anesthesia in these patients 
poses considerable challenges for the anesthesiologist. We report successful conduct of anesthesia 
in a patient with HOCM undergoing modified radical mastectomy (MRM).
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Case Report
A 60 year old female was scheduled for MRM 
for carcinoma of the left breast. She was a known 
case of HOCM for 17 years. Past medical history 
revealed hypertension and diabetes since six years. 
An implantable cardioverter defibrillator (ICD) 
and permanent pacemaker (PPM) was inserted 15 
months earlier when she had presented with VT at 
our tertiary care university hospital. She was taking 
atenolol, amlodipine, aspirin and soluble insulin. She 
complained of breathlessness on climbing a flight of 
stairs and had an ejection systolic murmur in the mitral 
area. The routine laboratory investigations were within 
normal limits. Her echocardiogram showed gross 
concentric left ventricular hypertrophy with a Grade II 
diastolic dysfunction. There was also systolic anterior 
motion of anterior mitral leaflet resulting in severe 
LVOT obstruction with a peak gradient of 130 mmHg 
and severe mitral regurgitation.
The patient was premedicated with tablet 
midazolam 7.5 mg. The pacemaker was altered to a 
fixed mode at 70 b/minute and the ICD was turned off 
before taking the patient to OR. External defibrillator 
with electrocardiogram (ECG) was accompanied with 
the patient. After initiating monitoring with ECG lead 
II, non-invasive blood pressure, peripheral oxygen 
saturation and insertion of peripheral venous line, an 
arterial catheter was placed in the right radial artery 
under local anesthesia. General anesthesia was induced 
with fentanyl, etomidate and vecuronium and a size 7.0 
endotracheal tube was inserted smoothly. Intermittent 
positive pressure ventilation with 50% oxygen in air 
and isoflurane adjusted to 1.2 MAC with fentanyl 
and vecuronium boluses were used for maintenance 
of anesthesia. After induction a 7.5 French Swan 
sheath was inserted in right internal jugular vein for 
monitoring of central venous pressure (CVP) and a 
provision for floating a pulmonary artery catheter if 
there was a need. Sterile external pads for defibrillation 
and pacing were placed after ensuring that they were 
kept away from the surgical field and the ICD.
The procedure lasted three hours during which 
there was one episode of hypotension ten minutes after 
induction, which responded to a 200 ml bolus of normal 
saline and 100 micrograms phenylephrine. Thereafter 
she remained hemodynamically stable and her CVP 
was kept at 12-13 cmH2O. She was extubated at the end 
of the procedure after reversal of the neuromuscular 
block and was transferred to the coronary care unit 
(CCU) where the ICD was switched on and PPM 
mode was reverted to the preoperative status. Patient 
remained stable hemodynamically except for an 
episode of supraventricular tachycardia (SVT) on the 
first postoperative day, which was reverted by the ICD 
without any additional measures. She was discharged 
home on the seventh postoperative day.
Discussion
HOCM is a rare genetic disorder characterized 
by massive asymmetric myocardial hypertrophy. 
Systolic anterior motion of the mitral valve leads 
to LVOT obstruction and often precipitates mitral 
regurgitation3,4. Diastolic dysfunction occurs due 
to impaired ventricular compliance2. All these 
features were present in our patient. Factors such as 
tachycardia, hypovolaemia, vasodilation and increased 
cardiac contractility exacerbate the obstruction3. 
Anesthetic management entails maintenance of 
desired hemodynamic parameters, and management of 
specific complications like hypotension, dysrhythmias 
and congestive heart failure5,6.
Sinus rhythm is crucial in these patients because 
of the dependence of preload on atrial contraction. The 
synchronous contractile pattern induced by pacing 
may be therapeutic as pacing has been shown to be 
effective in reducing the pressure gradient between 
the left ventricle and the aorta7,8. In our patient the 
presence of dual chamber pacemaker was probably 
helpful in maintaining the hemodynamic state. The 
ICD needed to be inactivated during surgery to prevent 
its damage by cautery. It is important to arrange its 
prompt activation in the CCU. External pads were 
placed for delivery of shock if required. Our patient 
had a severe LVOT obstruction with peak gradient 
of 130 mmHg. Negative inotropic drugs like beta 
blockers and calcium channel blockers are used to 
decrease the degree of outflow tract obstruction4,9. Our 
patient was on both these agents which were continued 
perioperatively, while intraoperatively the dose 
dependent myocardial depression caused by inhalation 
anesthetics might have helped in this regards.
These patients should be given adequate 
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premedication to reduce stress. Avoidance of 
vasodilators and agents that increase contractility is 
essential during the anesthetic management2,9. Episodes 
of hypotension can be treated with volume replacement 
and/or vasoconstrictors like norepinephrine or 
phenylephrine. Our patient responded well to fluids 
and phenylephrine. We used IV fluids judiciously 
and kept the CVP at 12-13 cm of H2O as adequate 
preload is necessary to maintain optimal cardiac output 
and avoid undue increase in contractility because of 
hypovolemia9. Although CVP may be an inaccurate 
guide to filling pressures due to abnormalities in left 
ventricular compliance, we decided to monitor CVP 
with a provision of floating a pulmonary artery catheter 
if required as we were not expecting major fluid shifts 
during an MRM procedure.
Conclusion
HOCM is a rare disorder imposing challenging 
conditions for the anesthesiologist. Thorough 
understanding of the pathophysiology of the condition 
is mandatory. It is important to maintain adequate 
preload and afterload, prevent arrhythmias and 
minimize outflow obstruction. In our patient there was 
the additional consideration of the ICD which required 
to be turned off during the surgery.
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